Overall Status

Completed (2)

Active, not recruiting (1)

Phase

phase 2 (1)

Sponsor

Gynecologic Oncology Group (1)

Tesaro, Inc. (1)

University Hospital Southampton NHS Foundation Trust (1)

Collaborator

National Cancer Institute (NCI) (1)

University of Southampton (1)

Intervention

bevacizumab (1)

dostarlimab (1)

evaluation of cancer risk factors (1)

niraparib (1)

quality-of-life assessment (1)

questionnaire administration (1)

study of high risk factors (1)

Study Documents

Intervention Type

drug (1)

other (1)

procedure (1)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

Ovarian Neoplasm

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Ovarian Tumor Trial in United States (Dostarlimab, Bevacizumab, Niraparib)

Completed

Ovarian Neoplasm

Dostarlimab
+2 more

Birmingham, Alabama
+9 more

Feb 20, 2023

Cancer Diagnosis and Treatment on Everyday Life

Active, not recruiting

Breast Cancer Female
+17 more

Aberystwyth, United Kingdom
+110 more

Mar 16, 2021

Cancer in Women at Increased Genetic Risk of Ovarian Cancer

Completed

Breast Carcinoma
+3 more

Evaluation of Cancer Risk Factors
+3 more

Birmingham, Alabama
+140 more

Aug 31, 2020